Format

Send to

Choose Destination
See comment in PubMed Commons below
Hosp Med. 2002 Jul;63(7):421-5.

TOBI: reducing the impact of pseudomonal infection.

Author information

1
Department of Medical Microbiology, University of Edinburgh Medical School, Edinburgh EH8 9AG.

Abstract

Pseudomonas aeruginosa infection is associated with impaired lung function and reduced life expectancy in cystic fibrosis patients. Tobramycin nebulizer solution (TOBI, Chiron Corporation Ltd, Hounslow) has been specifically formulated for use against P. aeruginosa infection in the lung.

PMID:
12187603
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center